ABU DHABI, United Arab Emirates–(BUSINESS WIRE)–M42, a global health leader powered by artificial intelligence (AI), technology and genomics, and San Diego-based bioinformatics-led company Inocras, have announced a strategic collaboration to advance blood-based monitoring for cancer recurrence in the UAE. Through this partnership, the organizations will deploy Inocras’ MRDVision™ platform—a whole-genome technology suite combining comprehensive genomic profiling with personalized blood assays
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
